Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delayed seroconversion to HIV in a hemophiliac.

J von Hintzenstern1, G Jahn, K Mang

  • 1Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg.

Klinische Wochenschrift
|May 2, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

[Karl Lennert : 04.06.1921--27.08.2012].

Der Pathologe·2013
Same author

Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.

Klinische Padiatrie·2013
Same author

Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.

Leukemia·2012
Same author

Telemicroscopic conferences for children of the Perm territory with suspected or proven malignant solid tumors.

Klinische Padiatrie·2010
Same author

[The German Excellence Initiative : effects on the medical schools].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2009
Same journal

Klinische Wochenschrift·2020
Same journal

Pathological anatomy of malnutrition.

Klinische Wochenschrift·2010
Same journal

Consequences of chronic malnutrition in the clinical picture of internal diseases.

Klinische Wochenschrift·2010
Same journal

Use of stable isotopes in biology.

Klinische Wochenschrift·2010
Same journal

About applications of radioactive indicators in medicine and physiology.

Klinische Wochenschrift·2010
Same journal

Early diagnosis and assessment of the activity of pulmonary tuberculosis based on serological examinations.

Klinische Wochenschrift·2010
See all related articles

Human Immunodeficiency Virus (HIV) seroconversion was observed in a severe hemophilia B patient two years after switching to heat-treated prothrombin complex concentrates. This case highlights potentially longer HIV antibody detection periods in hemophiliacs.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Virology

Background:

  • Severe hemophilia B necessitates regular blood product transfusions.
  • Substitution therapy evolved to include heat-treated prothrombin complex concentrates (PPSB) to mitigate viral transmission risks.
  • Monitoring for infectious agents like HIV is crucial in immunocompromised patients.

Observation:

  • A 14-year-old boy with severe hemophilia B developed HIV.
  • Seroconversion occurred approximately two years after initiating heat-treated PPSB concentrates.
  • The patient had no prior history of HIV infection before the therapy change.

Findings:

  • Delayed HIV seroconversion can occur in hemophilia patients.
  • Heat-treated blood products may not entirely eliminate the risk of transmitting certain viruses.

Related Experiment Videos

  • The window period for HIV antibody detection might be longer than typically recognized.
  • Implications:

    • Clinical vigilance for HIV is essential in hemophilia patients, even after prolonged periods on treated products.
    • Further research into the efficacy and safety of various hemophilia treatments regarding viral transmission is warranted.
    • This case underscores the importance of long-term patient monitoring in hemophilia management.